Bridging the Gap
Molecular diagnostics has the potential to improve the quality of healthcare by improving the accuracy, simplicity and accessibility to advanced diagnostic solutions, even in remote areas where skilled manpower and infrastructure is a challenge.
Molecular diagnostics has limited access in India. As a result, doctors are often forced to make judgment calls based on incomplete information or send the patient samples across / outside the country (costly and time consuming) for accurate diagnosis.
Why RIVAARA?
India's first exclusive lab chain dedicated to molecular diagnostics.
Processed more than One Million specimens since inception
Dedicated Research & Development team for continuous innovation
Robust testing protocols for accurate and reproducible results
Report Interpretation by a panel of Medical Experts
Trust of > 1000 hospitals and doctors across India
Why Molecular Diagnostics?
Helps escalate / de-escalate to appropriate antibiotic therapy
Robust antimicrobial stewardship
Higher sensitivity compared to traditional methods
Fastest detection of pathogens (Bacteria / Viruses / Fungi / Parasites)
Early detection of drug resistance genes
Affordability
Distance between the place where the test is conducted and where it is sent for diagnosis due to limited PCR Labs leads to delay in reporting and makes these tests expensive. This has kept HCPs deprived from doing many “confirmatory” tests in infectious disease.
Accessibility
For a population of over 1.3 billion, there are only around 400 PCR machines in the entire country. With growing disease burdens, access will be a key growth driver. This gives immense scope to innovate and commercialise PCR tests for India specific diseases.
Awareness
Many doctors are unaware of the complete benefits of Molecular Diagnostics & POC technologies. Lack of education channels within the industry has further added to limited percolation of latest technologies and advancements amongst HCPs.
